Adjuvant combinations of NKT activator, CD40 agonist, and optional antigen, the use through inducing synergistic cellular immunity

Details for Australian Patent Application No. 2008246149 (hide)

Owner Immurx, Inc.

Inventors Ahonen, Cory; Noelle, Randolph

Agent Watermark

Pub. Number AU-A-2008246149

PCT Pub. Number WO2008/133983

Priority 60/907,976 25.04.07 US

Filing date 25 April 2008

Wipo publication date 6 November 2008

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 39/38 (2006.01) Medicinal preparations containing antigens or antibodies - Antigens from snakes

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/133983 Priority application(s): WO2008/133983

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008246150-Combinations of gene deletions for live attenuated shigella vaccine strains

2008246139-Synthetic expression vectors for insect cells